文献速递先天性心脏病外科

当代心外膜开窗Fontan术后的乳糜胸与胸腔积液

Chylothorax and pleural effusion in contemporary extracardiac fenestrated fontan completion.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-11-21

该研究纳入2000至2013年间接受Fontan手术的324例患者,比较乳糜胸组与非乳糜胸组的中长期结局。乳糜胸发生率为24%(78例),乳糜胸组胸管留置时间及住院时间均较长,无死亡生存率及无复合不良事件生存率均较低。乳糜胸的发生难以预测。

要点

  • 乳糜胸发生率为24%(78/324),乳糜胸组胸管留置时间中位18天 vs 非乳糜胸组9天(P<.000)。
  • 乳糜胸组住院时间中位19天 vs 非乳糜胸组10天(P<.000),8例(10.3%)需胸导管结扎。
  • 乳糜胸组无死亡生存率较低(P=.013),无复合不良事件生存率较低(P=.021)。

核心结论

  • Fontan术后发生乳糜胸可能是较差中期临床结局的标志。
  • 由于乳糜胸的多因素性质及仅在Fontan术后才显现的淋巴代偿能力参与,乳糜胸的发生难以预测。

研究设计与样本

  • 研究纳入2000至2013年间接受Fontan手术的324例患者。
  • 乳糜胸定义为术后第5天及以后引流出≥5 mL/kg/天的乳糜微粒阳性胸腔引流液,或引流液中淋巴细胞>80%。
  • 采用Kaplan-Meier法和log-rank检验比较乳糜胸组与非乳糜胸组的结局。
  • 采用多变量logistic回归分析乳糜胸的独立预测因素,采用多变量广义负二项回归分析任何胸管引流天数的独立预测因素。

主要发现

  • 324例患者中78例(24%)发生乳糜胸。
  • 乳糜胸组胸管留置时间中位18天 vs 非乳糜胸组9天(P<.000)。
  • 乳糜胸组住院时间中位19天 vs 非乳糜胸组10天(P<.000)。
  • 8例(10.3%)需要胸导管结扎。
  • 乳糜胸组无死亡生存率较低(P=.013),无复合不良事件生存率较低(P=.021)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We hypothesized that chylothorax could be a sign of intolerance to the Fontan physiology, and thus patients who develop chylothorax or pleural effusion have worse medium-term to long-term survival. METHODS: A total of 324 patients who underwent the Fontan operation between 2000 and 2013 were included. Chylothorax was defined as ≥5 mL/kg/day of chylomicron-positive chest drainage fluid no earlier than postoperative day 5 or drainage with >80% lymphocytes. Outcomes were compared between the chylothorax and non-chylothorax groups by the Kaplan-Meier method and log-rank test. Independent predictors of chylothorax and number of days of any chest drainage were analyzed with multivariable logistic regression and multivariable generalized negative binomial regression for count data, respectively. RESULTS: Chylothorax occurred in 78 patients (24%). Compared with the non-chylothorax group, the chylothorax group had a longer duration of chest tube requirement (median, 18 days vs 9 days; P < .000) and a longer length of hospital stay (median, 19 days vs 10 days; P < .000). Eight patients (10.3%) required thoracic duct ligation. The chylothorax group had lower freedom from death (P = .013) and from composite adverse events (P = .021). No predictor was found for chylothorax. Pulmonary atresia (P = .031) and pre-Fontan pulmonary artery pressure (P = .01) were predictive of prolonged pleural effusion (>14 days). CONCLUSIONS: Occurrence of chylothorax following the Fontan operation can be a marker of poorer medium-term clinical outcomes. It is difficult to predict occurrence of chylothorax owing to its multifactorial nature and involvement of lymphatic compensatory capacity that is unmasked only after the Fontan operation.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Lo Rito M, Al-Radi OO, Saedi A, et al. Chylothorax and pleural effusion in contemporary extracardiac fenestrated fontan completion. J Thorac Cardiovasc Surg. 2017. PMID: 29249497. doi:10.1016/j.jtcvs.2017.11.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。